Hepatitis viral aguda tipo A fulminante

Fulminant acute viral hepatitis type A

Keywords: Acute viral hepatitis, hepatitis A virus, fulminant hepatitis

Abstract

The clinical course of Hepatitis A virus (HAV) infection is usually benign and self-limited in more than 90% of cases; however, fulminant liver failure is described within its atypical forms of presentation. Atypical forms of HAV infection have been poorly studied and are rarely taken into account as a differential diagnosis in clinical practice.

Downloads

Download data is not yet available.

Author Biography

Yraima Larreal, Universidad del Zulia. Maracaibo, Venezuela.

Sección de Virología del Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia. Maracaibo, Venezuela.

References

Matthew A, Sonali P. Viral hepatitis: Past, present, and future. World J Gastroenterol 2022; 28(14): 1405–1429.

Xiangxi W, Jingshan R, Qiang G, Zhongyu H, Yao S, Xuemei L, Rowlands D, Weidong Y, Junzhi W, David S, Zihe R, Elizabeth E. Hepatitis A virus and the origins of picornaviruses. Nature 2015; 517(7532): 85–88.

Genus: Hepatovirus—Picornaviridae—Positive-Sense RNA Viruses—ICTV. [(accessed on 9 September 2021)]. Available online: https://talk.ictvonline.org/ictv-reports/ictv_online_report/positive-sense-rna-viruses/w/picornaviridae/709/genus-hepatovirus.

Migueres M, Lhomme S, Izopet J. Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses 2021; 13(10): 1900.

Ajmera G, Xia G, Vaughan J, Forbi L, Ganova Y, Khudyakov C, Opio R, Taylor R, Restrepo S, Munoz R, Fontana W, Lee M, the Acute Liver Failure Study Group. What factors determine the severity of hepatitis A-related acute liver failure? Journal of viral hepatitis 2011; 18(7):167-174.

Munoz-Martínez S, Díaz-Hernández H, Suárez-Flores D, Sánchez-ÁvilaJ, Gamboa-Domínguez A, García-Juárez I, Torrea A. Manifestaciones atípicas de la infección por el virus de la hepatitis A. Revista de Gastroenterología de México 2018. 83(2): 134-143.

Lorio N, John S. Hepatitis A 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459290/).

Pintó R, Pérez F, Costafreda M, Chavarria G, Guix S, Ribes E, Bosch A. Pathogenicity and Virulence of Hepatitis A Virus. Virulence 2021; 12:1174–1185.

Schiff E. Manifestaciones clínicas atípicas de la hepatitis A. Vacuna 1992; 10(1): 18-20.

Moreno R. Hepatitis fulminante. Revista de Gastroenterología de México. 2013;78(1):101-102.

Lee HW, Chang DY, Moon HJ. Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A. PLoS One 2015;10(6):e0130728.

Kashyap P, Deka M, Medhi S, Dutta S, Kashyap K, Kumari N. Association of Toll-like receptor 4 with hepatitis A virus infection in Assam. Acta Virol. 2018;62(1):58-62.

Gohal G. A fatal hepatitis A virus with dengue fever co-infection. IDCases. 2019.

Figen O, Emre B, Oğuz C, Namik O. Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure. Turk J Gastroenterol 2006;17(2):148-50.

Anahita S, Sudabeh A, Neda A. A case of COVID-19 with concomitant hepatitis A infection. Rev Esp Enferm 2022; 114 (3): 174-175.

Larreal Y, Valero N, Estévez J, Reyes I, Maldonado M, Espina L, Arias J, Meleán E, Añez G, Atencio R. Alteraciones Hepáticas en Pacientes con Dengue. Investigación Clínica 2005; 46(2): 169-178.

Larreal Y, Andrade E, Cuevas Y, Mendoza A, Montiel M, Levy A, Valero N. Pruebas de funcionalismo hepático en pacientes con infección viral aguda. Acta bioquím. clín. latinoam 2012. 28(1): 38-46.

Echevarría J. Etiology and pathogenesis of viral hepatitis. Enfermedades Infecciosas y Microbiología clínica 2006; 24(1):45-56.

Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, Hynan L, Lee WM, Fontana RJ. Acute Liver Failure Study Group. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 2006; 44: 1589–1597.

Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar , Acharya SK, Bernal W, O'Grady J, Kim YJ. A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology 2019; 70:621–629.

Rela M, Kaliamoorthy I, Reddy MS. Current status of auxiliary partial orthotopic liver transplantation for acute liver failure. Liver Transpl 2016; 22: 1265–12.

Suarez C, Lombo C. Rol del lactato en pacientes con falla hepática. Universitas Medica 2021; 62(3).

WHO position paper on hepatitis A vaccines 2012. Wkly Epidemiol Rec. 2012; 87: 261–76.

Nelson NP, Link-Gelles R, Hofmeister MG, Romero JR, Moore KL, Ward JW, Schillie SF. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel. MMWR Morb Mortal Wkly Rep. 2018; 67: 1216–1220.
Published
2022-06-23
How to Cite
Larreal, Y. (2022). Hepatitis viral aguda tipo A fulminante: Fulminant acute viral hepatitis type A. Revista Profesional HígadoSano, (23), 26-34. https://doi.org/10.5281/zenodo.6738938
Section
Artículos